These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
578 related articles for article (PubMed ID: 29704170)
1. Comparison of Hematologic and Other Prognostic Markers in Metastatic Colorectal Cancer. Mercier J; Voutsadakis IA J Gastrointest Cancer; 2019 Sep; 50(3):493-506. PubMed ID: 29704170 [TBL] [Abstract][Full Text] [Related]
2. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab. Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096 [TBL] [Abstract][Full Text] [Related]
3. The platelets-neutrophils to lymphocytes ratio: a new prognostic marker in metastatic colorectal cancer. Mercier J; Voutsadakis IA J Gastrointest Oncol; 2018 Jun; 9(3):478-486. PubMed ID: 29998013 [TBL] [Abstract][Full Text] [Related]
4. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis. Wu Y; Li C; Zhao J; Yang L; Liu F; Zheng H; Wang Z; Xu Y World J Surg Oncol; 2016 Nov; 14(1):289. PubMed ID: 27852294 [TBL] [Abstract][Full Text] [Related]
5. Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, neutrophil-platelet score and prognostic nutritional index: do they have prognostic significance in metastatic pancreas cancer? Dogan M; Algin E; Guven ZT; Baykara M; Kos TF; Bal O; Zengin N Curr Med Res Opin; 2018 May; 34(5):857-863. PubMed ID: 29161926 [TBL] [Abstract][Full Text] [Related]
6. Pre-treatment inflammatory indexes as predictors of survival and cetuximab efficacy in metastatic colorectal cancer patients with wild-type RAS. Yang J; Guo X; Wang M; Ma X; Ye X; Lin P Sci Rep; 2017 Dec; 7(1):17166. PubMed ID: 29215037 [TBL] [Abstract][Full Text] [Related]
7. Preoperative Neutrophil-to-Lymphocyte Ratio is a Better Prognostic Serum Biomarker than Platelet-to-Lymphocyte Ratio in Patients Undergoing Resection for Nonmetastatic Colorectal Cancer. Choi WJ; Cleghorn MC; Jiang H; Jackson TD; Okrainec A; Quereshy FA Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S603-13. PubMed ID: 25900206 [TBL] [Abstract][Full Text] [Related]
8. The Role of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Platelets in the Prognosis of Metastatic Renal Cell Carcinoma. Huszno J; Kolosza Z; Mrochem-Kwarciak J; Rutkowski T; Skladowski K Oncology; 2019; 97(1):7-17. PubMed ID: 31048577 [TBL] [Abstract][Full Text] [Related]
9. Hematologic Markers of Lung Metastasis in Stage IV Colorectal Cancer. Abu-Shawer M; Abu-Shawer O; Souleiman M; Akkawi M; Alshakhatreh O; Altamimi T; Al-Omari A; Al-Hussaini M J Gastrointest Cancer; 2019 Sep; 50(3):428-433. PubMed ID: 29589285 [TBL] [Abstract][Full Text] [Related]
10. Preoperative platelet-lymphocyte ratio is an independent prognostic marker and superior to carcinoembryonic antigen in colorectal peritoneal carcinomatosis patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Bong TSH; Tan GHC; Chia C; Soo KC; Teo MCC Int J Clin Oncol; 2017 Jun; 22(3):511-518. PubMed ID: 28138878 [TBL] [Abstract][Full Text] [Related]
11. Preoperative neutrophil-to-lymphocyte ratio and plateletto- lymphocyte ratio as new prognostic factors for patients with colorectal cancer. Mahsuni Sevinc M; Riza Gunduz U; Kinaci E; Armagan Aydin A; Bayrak S; Umar Gursu R; Gunduz S J BUON; 2016; 21(5):1153-1157. PubMed ID: 27837617 [TBL] [Abstract][Full Text] [Related]
12. Hemoglobin, albumin, lymphocyte, and platelet score and neutrophil-to-lymphocyte ratio are novel significant prognostic factors for patients with small-cell lung cancer undergoing chemotherapy. Yang N; Han X; Yu J; Shu W; Qiu F; Han J J Cancer Res Ther; 2020 Sep; 16(5):1134-1139. PubMed ID: 33004760 [TBL] [Abstract][Full Text] [Related]
13. Combination of preoperative neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte-lymphocyte ratio: a superior prognostic factor of endometrial cancer. Cong R; Kong F; Ma J; Li Q; Wu Q; Ma X BMC Cancer; 2020 May; 20(1):464. PubMed ID: 32448185 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of neutrophil-to lymphocyte ratio and platelet-to lymphocyte ratio in older patients with metastatic colorectal cancer. Cruz-Ramos M; Del Puerto-Nevado L; Zheng B; López-Bajo R; Cebrian A; Rodríguez-Remirez M; García-García L; Solanes-Casado S; García-Foncillas J J Geriatr Oncol; 2019 Sep; 10(5):742-748. PubMed ID: 30327283 [TBL] [Abstract][Full Text] [Related]
15. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer? Deng M; Ma X; Liang X; Zhu C; Wang M Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461 [TBL] [Abstract][Full Text] [Related]
16. A High Monocyte-to-Lymphocyte Ratio Predicts Poor Prognosis in Patients with Advanced Gallbladder Cancer Receiving Chemotherapy. Choi YH; Lee JW; Lee SH; Choi JH; Kang J; Lee BS; Paik WH; Ryu JK; Kim YT Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1045-1051. PubMed ID: 30842131 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer. Zhao G; Liu N; Wang S; Guo J; Song X; Qi Y; Qiu W; Lv J Medicine (Baltimore); 2020 Mar; 99(10):e19405. PubMed ID: 32150090 [TBL] [Abstract][Full Text] [Related]
18. Elevated platelet to lymphocyte ratio predicts poor prognosis after hepatectomy for liver-only colorectal metastases, and it is superior to neutrophil to lymphocyte ratio as an adverse prognostic factor. Neofytou K; Smyth EC; Giakoustidis A; Khan AZ; Cunningham D; Mudan S Med Oncol; 2014 Oct; 31(10):239. PubMed ID: 25218270 [TBL] [Abstract][Full Text] [Related]
19. Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer. Lian L; Xia YY; Zhou C; Shen XM; Li XL; Han SG; Zheng Y; Mao ZQ; Gong FR; Wu MY; Chen K; Tao M; Li W Cancer Biomark; 2015; 15(6):899-907. PubMed ID: 26444485 [TBL] [Abstract][Full Text] [Related]
20. Prognostic Significance of Total Lymphocyte Count, Neutrophil-to-lymphocyte Ratio, and Platelet-to-lymphocyte Ratio in Limited-stage Small-cell Lung Cancer. Suzuki R; Wei X; Allen PK; Cox JD; Komaki R; Lin SH Clin Lung Cancer; 2019 Mar; 20(2):117-123. PubMed ID: 30611672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]